Diabetes and Hypertension: Clinical Update-Reference-Cited by-同舟云学术

Diabetes and Hypertension: Clinical Update

Published:2018-03-14 Issue:5 Volume:31 Page:515-521
ISSN:0895-7061
Container-title:American Journal of Hypertension
language:en
Short-container-title:

Author:

Khangura Darshan¹²,Kurukulasuriya L Romayne¹²,Whaley-Connell Adam¹²³⁴⁵,Sowers James R¹²³⁵⁶

Affiliation:

1. School of Medicine, Diabetes and Cardiovascular Center, University of Missouri–Columbia, Columbia, Missouri, USA

2. The Divisions of Endocrinology and Metabolism, University of Missouri–Columbia, Columbia, Missouri, USA

3. Department of Medicine, University of Missouri–Columbia, Columbia, Missouri, USA

4. Nephrology and Hypertension, University of Missouri–Columbia, Columbia, Missouri, USA

5. The Research Service at the Harry S Truman Memorial Veterans Hospital, University of Missouri–Columbia, Columbia, Missouri, USA

6. Department of Medical Pharmacology and Physiology, University of Missouri–Columbia, Columbia, Missouri, USA

Publisher

Oxford University Press (OUP)

Subject

Internal Medicine

Link

http://academic.oup.com/ajh/article-pdf/31/5/515/24649630/hpy025.pdf

Reference34 articles.

1. Hypertension Prevalence and Control Among Adults: United States, 2015–2016;Fryar,2017

2. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: a report of the American College of Cardiology/American Heart Association task force on clinical practice guidelines;Whelton;J Am Coll Cardiol,2017; [ ]

3. National Diabetes Statistics Report, 2017;Centers for Disease Control and Prevention,2017

4. 2013 ACC/AHA Guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines;Goff;Circulation,2014

5. 2013 ACC/AHA Guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines;Stone;J Am Coll Cardiol,2014; 63(25 ):2889–2934

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy and safety evaluation of SGLT2i on blood pressure control in patients with type 2 diabetes and hypertension: a new meta-analysis;Diabetology & Metabolic Syndrome;2023-06-07

2. Mechanism of canagliflozin-induced vasodilation in resistance mesenteric arteries and the regulation of systemic blood pressure;Journal of Pharmacological Sciences;2022-12

3. Disparities in Prevalence and Barriers to Hypertension Control: A Systematic Review;International Journal of Environmental Research and Public Health;2022-11-06

4. Dapagliflozin induces vasodilation in resistance-size mesenteric arteries by stimulating smooth muscle cell KV7 ion channels;Heliyon;2022-05

5. Single-Pill Combination to Improve Hypertension Treatment: Pharmaceutical Industry Development;International Journal of Environmental Research and Public Health;2022-03-31